4[1]Etminan M,Samii A.Pharmacoepidemiology I:a review of pharmacoepidemiologic study designs[J].Pharmacotherapy,2004,24(8):964-969.
5[2]Ferrari A,Pasciullo G,Savino G,et al.Headache treatment before and after the consultation of a specialized centre:a pharmacoepidemiology study[J].Cephalalgia,2004,24(5):356-362.
6[4]Hass D J,Lewis J D.Quality of manufacturer provided information on safety and efficacy claims for dietary supplements for colonic health[J].Pharmacoepidemiol Drug Saf,2006,15(8):578-586.
7[5]Chan K A,Hernandez-Diaz S.Pharmacoepidemiology and rheumatic disorders[J].Rheum Dis Clin North Am,2004,30(4):835-850.
9[9]Paterson J M,Laupacis A,Bassett K,et al.Using pharmacoepidemiology to inform drug coverage policy:initial lessons from a two-province collaborative[J].Health Aff(Millwood),2006,25(5):1436-1443.
